HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bauhinia purpurea lectin (BPA) binding of rat type I pneumocytes: alveolar epithelial alterations after radiation-induced lung injury.

Abstract
In the rat lung, we found that the Bauhinia purpurea lectin (BPA) specifically binds to the type I alveolar epithelial cells and to the alveolar macrophages. Double label fluorescence employing FITC-coupled Maclura pomifera lectin (MPA) and bBPA-avidin-Texas Red showed that BPA binding was confined to type I cells. In addition, a minor staining of the luminal border of the terminal bronchiolar epithelium was found. The sequence of tissue injury following X-radiation was examined in rats. BPA is a suitable marker which indicates epithelial changes during the early stage of pneumonitis and the subsequent development of fibrosis.
AuthorsM Kasper, D Schuh, M Müller
JournalExperimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie (Exp Toxicol Pathol) Vol. 46 Issue 4-5 Pg. 361-7 (Oct 1994) ISSN: 0940-2993 [Print] Germany
PMID7894248 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Bauhinia purpurea lectin
  • Lectins
  • Plant Lectins
  • maclurin
Topics
  • Animals
  • Disease Models, Animal
  • Dose-Response Relationship, Radiation
  • Epithelium (metabolism, pathology, radiation effects)
  • Histocytochemistry
  • Immunohistochemistry
  • Lectins (metabolism)
  • Lung (pathology, radiation effects)
  • Macrophages, Alveolar (metabolism, pathology, radiation effects)
  • Plant Lectins
  • Pulmonary Alveoli (metabolism, pathology, radiation effects)
  • Pulmonary Fibrosis (metabolism, pathology)
  • Radiation Injuries, Experimental (metabolism, pathology)
  • Radiation Pneumonitis (metabolism, pathology)
  • Rats
  • Rats, Inbred F344

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: